144 related articles for article (PubMed ID: 24915003)
1. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
[TBL] [Abstract][Full Text] [Related]
2. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
3. New m-calpain substrate-based azapeptide inhibitors.
Bánóczi Z; Tantos Á; Farkas A; Majer Z; Dókus LE; Tompa P; Hudecz F
J Pept Sci; 2013 Jun; 19(6):370-6. PubMed ID: 23613308
[TBL] [Abstract][Full Text] [Related]
4. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and investigation of dihydroxychalcones as calpain and cathepsin inhibitors.
Baek KH; Karki R; Lee ES; Na Y; Kwon Y
Bioorg Chem; 2013 Dec; 51():24-30. PubMed ID: 24095934
[TBL] [Abstract][Full Text] [Related]
6. The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.
Crawford C; Mason RW; Wikstrom P; Shaw E
Biochem J; 1988 Aug; 253(3):751-8. PubMed ID: 2845932
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
[TBL] [Abstract][Full Text] [Related]
8. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
9. Substrate/propeptide-derived endo-epoxysuccinyl peptides as highly potent and selective cathepsin B inhibitors.
Schaschke N; Assfalg-Machleidt I; Machleidt W; Moroder L
FEBS Lett; 1998 Jan; 421(1):80-2. PubMed ID: 9462845
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of di- and tripeptidyl aldehydes on calpains and cathepsins.
Sasaki T; Kishi M; Saito M; Tanaka T; Higuchi N; Kominami E; Katunuma N; Murachi T
J Enzyme Inhib; 1990; 3(3):195-201. PubMed ID: 2079636
[TBL] [Abstract][Full Text] [Related]
11. Studies on aromatic compounds: inhibition of calpain I by biphenyl derivatives and peptide-biphenyl hybrids.
Montero A; Alonso M; Benito E; Chana A; Mann E; Navas JM; Herradón B
Bioorg Med Chem Lett; 2004 Jun; 14(11):2753-7. PubMed ID: 15125927
[TBL] [Abstract][Full Text] [Related]
12. Calpain inhibition by alpha-ketoamide and cyclic hemiacetal inhibitors revealed by X-ray crystallography.
Cuerrier D; Moldoveanu T; Inoue J; Davies PL; Campbell RL
Biochemistry; 2006 Jun; 45(24):7446-52. PubMed ID: 16768440
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and evaluation of new tripeptide phosphonate inhibitors of MMP-8 and MMP-2.
Agamennone M; Campestre C; Preziuso S; Consalvi V; Crucianelli M; Mazza F; Politi V; Ragno R; Tortorella P; Gallina C
Eur J Med Chem; 2005 Mar; 40(3):271-9. PubMed ID: 15725496
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of 4-quinolinone 2-carboxamides as calpain inhibitors.
Nam DH; Lee KS; Kim SH; Kim SM; Jung SY; Chung SH; Kim HJ; Kim ND; Jin C; Lee YS
Bioorg Med Chem Lett; 2008 Jan; 18(1):205-9. PubMed ID: 18024028
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of novel piperidine carboxamide derived calpain inhibitors.
Lubisch W; Hofmann HP; Treiber HJ; Möller A
Bioorg Med Chem Lett; 2000 Oct; 10(19):2187-91. PubMed ID: 11012026
[TBL] [Abstract][Full Text] [Related]
16. Epoxysuccinyl peptide-derived cathepsin B inhibitors: modulating membrane permeability by conjugation with the C-terminal heptapeptide segment of penetratin.
Schaschke N; Deluca D; Assfalg-Machleidt I; Höhneke C; Sommerhoff CP; Machleidt W
Biol Chem; 2002 May; 383(5):849-52. PubMed ID: 12108551
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.
Stern I; Schaschke N; Moroder L; Turk D
Biochem J; 2004 Jul; 381(Pt 2):511-7. PubMed ID: 15084146
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and bioactivities of tasiamide B derivatives as cathepsin D inhibitors.
Li Z; Bao K; Xu H; Wu P; Li W; Liu J; Zhang W
J Pept Sci; 2019 Apr; 25(4):e3154. PubMed ID: 30734395
[TBL] [Abstract][Full Text] [Related]
20. Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
Czaplewski C; Grzonka Z; Jaskólski M; Kasprzykowski F; Kozak M; Politowska E; Ciarkowski J
Biochim Biophys Acta; 1999 May; 1431(2):290-305. PubMed ID: 10350606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
